Search results
Results from the WOW.Com Content Network
Psilocybin-containing mushrooms. Psilocybin therapy is the use of psilocybin (the psychoactive ingredient in psilocybin mushrooms) in treating a range of mental health conditions, such as depression, anxiety, addictions, [1] obsessive compulsive disorder (OCD), and psychosis. [2] It is one of several forms of psychedelic therapy under study.
Psilocybin is the psychedelic component of magic mushrooms and a synthetic version of it coupled with intensive therapy is in clinical trials at Ohio State, said Dr. Alan Davis, an associate ...
“The study suggests that psilocybin therapy might be a more holistic treatment option for depression, addressing both the symptoms of depression and overall well-being. This could make a ...
Over the last five years, research on psychedelic drugs as part of a therapy for mental conditions such as post-traumatic stress disorder, depression, anxiety and addiction has exploded.
The psychedelic therapy method was initiated by Humphry Osmond and Abram Hoffer (with some influence from Al Hubbard) and replicated by Keith Ditman, [91] [92] and is more closely aligned to transpersonal psychology than to traditional psychoanalysis. [citation needed] Most recent research on psychedelic therapy has used psilocybin or ayahuasca ...
Psychedelic therapy (or psychedelic-assisted therapy) is the proposed use of psychedelic drugs to treat mental disorders. [59] As of 2021, psychedelic drugs are controlled substances in most countries and psychedelic therapy is not legally available outside clinical trials, with some exceptions. [34] [60]
A new study compared psilocybin — the active compound in magic mushrooms, with a common antidepressant medication. During 6 months of follow up, both drugs improved depressive symptoms, but ...
Psychedelic treatments for trauma-related disorders are the use of psychedelic substances, either alone or used in conjunction with psychotherapy, to treat trauma-related disorders. [1] Trauma-related disorders, such as post-traumatic stress disorder (PTSD), have a lifetime prevalence of around 8% in the US population. [ 2 ]